Integrating the “Immunome” in the Stratification of Myelodysplastic Syndromes and Future Clinical Trial Design

Myelodysplastic syndromes (MDS) are characterized by ineffective hematopoiesis and often include a dysregulation and dysfunction of the immune system. In the context of population aging, MDS incide...